The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
Type 2 diabetes is commonly accompanied by a low level of high density lipoprotein cholesterol (HDL-C) that contributes to the increased cardiovascular risk associated with this condition. Given that HDLs have the ability to improve increase the uptake of glucose by skeletal muscle and to stimulate...
Main Author: | Philip J. Barter |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2011-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-101.pdf |
Similar Items
-
The mixed benefit of low lipoprotein(a) in type 2 diabetes
by: Michel P. Hermans, et al.
Published: (2017-09-01) -
Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment
by: Marie‐Claude Brulhart‐Meynet, et al.
Published: (2021-03-01) -
High-density lipoprotein: Quality versus quantity in type 2 diabetes mellitus
by: Aparna R Bitla, et al.
Published: (2019-01-01) -
Association of high-density lipoprotein cholesterol subfractions with insulin resistance in Nigerians with type 2 diabetes mellitus
by: Chikezie Hart Onwukwe, et al.
Published: (2021-01-01) -
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
by: Kyoung Hwa Ha, et al.
Published: (2018-02-01)